ArkBio Advances Global Influenza Research with New Antiviral Drug Trial in Australia ArkBio has begun dosing healthy volunteers in Australia for Phase I trial of its innovative antiviral drug, AK0406, targeting influenza infections.

ArkBio Advances Global Influenza Research with New Antiviral Drug Trial in Australia #Shanghai #Australia #ArkBio #Antiviral_Drug #AK0406